Aranesp 300 MCG/0.6 ML syringe 0.6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,203
Award facts
- Contract value 100% obligated
- $4,203.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,203.18 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Aranesp 300 mcg/0.6 ml syringes. This is a firm fixed-price contract with a completion date of January 23, 2026, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take place at the company's corporate headquarters in Conshohocken, Pennsylvania. Aranesp is a specialty pharmaceutical treatment for anemia, reflecting the critical nature of pharmaceutical procurement through DLA's medical supply chain.
This delivery order operates under AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical extending through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that regularly fulfills federal medical procurement requirements across multiple therapeutic domains including specialty medications, generic and brand-name drugs, vaccines, and medical devices. The firm's extensive portfolio of federal contracts demonstrates its established capability to meet defense medical supply needs through open competition.
Quick answers
Who was awarded contract SPE2DR26FQV2G?
SPE2DR26FQV2G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQV2G worth?
The government has obligated $4,203 on SPE2DR26FQV2G.
Is contract SPE2DR26FQV2G an order under another contract?
Yes. SPE2DR26FQV2G is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2G competed?
The extent of competition for SPE2DR26FQV2G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award